Cardinal Health, Inc. (CAH) Covered Calls
Cardinal Health, Inc. is a leading healthcare services and products company that serves as a vital link between manufacturers and providers. Headquartered in Dublin, Ohio, the company distributes pharmaceuticals and medical products, operates nuclear pharmacies, and provides data solutions for healthcare facilities. With a presence in more than 30 countries, Cardinal Health specializes in specialty pharmaceutical distribution and home-health solutions to improve patient care efficiency.
You can sell covered calls on Cardinal Health, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CAH (prices last updated Tue 2:50 PM ET):
| Cardinal Health, Inc. (CAH) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 218.89 | -3.39 | 218.78 | 219.00 | 665K | 32 | 52 |
| Covered Calls For Cardinal Health, Inc. (CAH) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Mar 20 | 220 | 3.40 | 215.60 | 1.6% | 53.1% | |
| Apr 17 | 220 | 7.20 | 211.80 | 3.6% | 33.7% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Cardinal Health, Inc. (CAH) is one of the "Big Three" pharmaceutical distributors in the United States, facilitating the daily delivery of essential medications and medical supplies to nearly 90% of U.S. hospitals. The company’s business model is organized into two primary segments: Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution. By leveraging a massive logistics infrastructure and sophisticated data analytics, Cardinal Health helps healthcare providers manage complex inventory and improve clinical outcomes while reducing operational costs.
By early 2026, Cardinal Health has successfully pivoted its growth strategy toward high-margin Specialty Distribution and at-Home Solutions. A major milestone in early 2026 was the launch of the ContinuCare™ Pathway program, an innovative platform that simplifies diabetes supply management for thousands of retail pharmacies. Additionally, the company has integrated its recent acquisition of Solaris Health, significantly expanding its footprint in specialty therapeutic areas like urology and oncology. Management has successfully navigated 2026 Medicare price negotiations by transitioning manufacturer agreements to ensure stable compensation for its distribution role, maintaining a robust cash flow profile that supports its long-standing commitment to shareholder returns.
Competitive Landscape
The competitive landscape for Cardinal Health is dominated by a tight oligopoly of national distributors and specialized medical suppliers. Primary rivals that are publicly traded on the NYSE and offer highly active options markets include McKesson Corporation and Cencora, Inc.. While McKesson and Cencora lead in total pharmaceutical volume, Cardinal Health competes aggressively in the medical-surgical and direct-to-patient home delivery markets.
Other notable competitors in the healthcare services and distribution sectors with active options trading include Henry Schein, Inc. and Alcon Inc.. Cardinal Health distinguishes itself through its Nuclear and Precision Health Solutions division, which is one of the largest radiopharmaceutical networks in the country. This niche expertise, combined with its "asset-light" medical manufacturing strategy and its focus on the burgeoning "hospital-at-home" trend, provides a diversified revenue stream that is less vulnerable to the drug-pricing fluctuations that can impact pure-play pharmaceutical wholesalers.
Strategic Outlook
Strategic innovation is currently focused on BioPharma Solutions and the expansion of the Sonexus™ patient support hub, which utilizes AI to automate the patient journey and increase adherence for complex specialty therapies. The company is prioritizing the build-out of new, highly automated distribution centers across the United States to enhance regional density and reduce delivery times for time-sensitive medical products. These efforts are designed to capture the growing demand for specialty medications and chronic disease management in a decentralized healthcare environment.
The long-term outlook involves a disciplined capital allocation framework focused on maintaining a strong investment-grade balance sheet while funding strategic "tuck-in" acquisitions. Management is prioritizing Consistent Capital Returns, characterized by a steady quarterly dividend and an active share repurchase program fueled by robust free cash flow. By leveraging its critical role in the biopharma supply chain and its leadership in home-health technology, Cardinal Health, Inc. aims to remain a resilient and essential partner in the evolving global healthcare landscape.
| Top 10 Open Interest For Mar 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | QQQ covered calls | 1. | CTMX covered calls | |
| 2. | SLV covered calls | 7. | EWZ covered calls | 2. | PATH covered calls | |
| 3. | EEM covered calls | 8. | FXI covered calls | 3. | RCAT covered calls | |
| 4. | SPY covered calls | 9. | GLD covered calls | 4. | FLY covered calls | |
| 5. | IBIT covered calls | 10. | KWEB covered calls | 5. | USO covered calls | |
Want more examples? CAG Covered Calls | CAI Covered Calls
Risk Disclosure: Trading options involves significant risk and is not suitable for all investors. The information provided on this website is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. Nothing contained on this site is an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities or financial instruments.
Covered Call Strategy Risks: While covered call writing is often considered a conservative options strategy, it is not without risk. By selling a covered call, you are limiting your potential upside profit from the underlying stock. You remain exposed to the full downside risk of owning the underlying stock. In the event of a significant decline in the stock price, the premium received may not be sufficient to offset your losses.
No Guarantee of Performance: Past performance is not indicative of future results. Any examples, calculations, or hypothetical scenarios presented on this site are for illustrative purposes only and do not guarantee future returns or outcomes. Market conditions, liquidity, and trading system failures can affect your ability to execute trades at desired prices.
You should consult with a qualified professional advisor and conduct your own due diligence before making any investment decisions. By using this website, you acknowledge that you are responsible for your own investment decisions and agree to release this site and its affiliates from any liability relating to your use of this information. See the OCC's Characteristics and Risks of Standardized Options for more info.
